secwatch.observer — SEC 8-K summary
======================================

Issuer:     Stereotaxis, Inc. (STXS)
CIK:        0001289340
Form:       8-K
Filed at:   2026-04-15T23:59:59+00:00
Accession:  0001493152-26-016685
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stereotaxis to acquire Robocath for $20M initial plus up to $25M in earnouts
----------------------------------------------------------------------------

- Total consideration up to $45M: $20M upfront (cash/stock) plus earnouts of $10M (FDA approval) and $15M (commercial milestones).
- Expected close in July 2026, subject to French regulatory clearance and Stereotaxis debt restructuring.
- Interim financing of approx. €1.3M provided to Robocath between signing and closing.
- Stock consideration capped at 19.9% of outstanding shares pre-closing unless shareholder approval obtained.
- Earnout targets based on next-gen interventional device FDA approval and specified product sales thresholds.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1289340/000149315226016685/0001493152-26-016685-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1289340/000149315226016685/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-016685

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer